Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth

11. Juni 2026 aktualisiert von: Region Örebro County

Society has become increasingly digital, and many everyday services have been replaced by digital self-service solutions. This puts greater demands on our vision and our ability to interpret what we see. At the same time, the number of children with nearsightedness (myopia) has increased rapidly. In some parts of Asia, as many as 60-70% of students in seventh grade are nearsighted (1), and a similar trend may develop in Europe.

Nearsightedness is becoming a growing challenge in pediatric eye care. High myopia can lead to complications that require early detection and prevention. There are now several ways to slow down its progression, such as special contact lenses, glasses, and eye drops (2). However, the scientific evidence for these treatments varies, and there are currently no national or Nordic guidelines on how to use them. In addition, myopia may have a major impact on children's quality of life.

Currently, there is no validated Swedish questionnaire that measures vision related quality of life across all age groups in children and adolescents. To address this, researchers in the United States developed the Pediatric Eye Questionnaire (PedEyeQ) in 2019 (3). It is already available in English and Spanish and takes into account both the child's and the parent's perspectives on vision and daily life.

The aim of this study is to translate, culturally adapt and test the PedEyeQ in Swedish children and adolescents, and to investigate how common refractive errors, especially nearsightedness - are today compared to 20-30 years ago.

The study will include 300 healthy children and adolescents aged 0-17 years, divided into three age groups: 0-4 years, 5-11 years, and 12-17 years. Participants will be recruited through child health centers, preschools, and schools in the Örebro region.

All participants will visit the eye clinic for a detailed eye examination, including:

  • Testing distance and near visual acuity
  • Measuring eye refraction (with and without eye drops that temporarily relax the eye's focusing muscles)
  • Imaging the retina using Optical Coherence Tomography (OCT)
  • Measuring eye length and corneal shape
  • Checking eye pressure and contrast sensitivity

Children and parents will also answer questions about how the child's vision affects everyday life and wellbeing. For the youngest children (0-4 years), only parents will answer the questions.

The PedEyeQ will be translated into Swedish following the International Society for Pharmacoeconomics and Outcome Research (ISPOR) (4) guidelines to make sure it is culturally relevant and easy to understand. The Swedish version will then be tested to ensure it is accurate and reliable.

All information collected in the study will be stored securely and anonymously. The results will also be compared with data from a similar cohort conducted in the 1990s to see if vision problems have become more common over time (5).

This project will provide new knowledge about children's vision and quality of life in Sweden. A validated Swedish version of the PedEyeQ can be used both in healthcare and research to better understand how vision affects children's daily lives. The study will also offer updated information on the frequency of refractive errors among Swedish children and adolescents - knowledge that is essential for developing preventive strategies and improving eye care for the future.

Studienübersicht

Status

Rekrutierung

Detaillierte Beschreibung

Society has undergone extensive digitalization, in which many service functions have been replaced by digital self-service solutions. This development requires a good visual function and on the ability to interpret visual information. Concurrently, there has been a marked increase in nearsightedness (myopia) among children. In parts of Asia, 60-70% of students in seventh grade are myopic (1), and a similar trend may emerge in Europe.

The increase of myopia might become major challenge within pediatric ophthalmology. High myopia can lead to vision-related complications that require early diagnosis and preventive measures. Preventive interventions-such as specialized contact lenses, spectacle designs, and pharmacological treatments as for example low-dose atropine, are now available on the market (2). However, the scientific evidence supporting these methods varies, and there is currently no national or Nordic consensus regarding their implementation. Furthermore the condition may have substantial implications for affected children's quality of life.

At present, there is no validated Swedish-language instrument for assessing vision-related quality of life in children and adolescents that encompasses all age groups, despite the widely recognized importance of such measures from both a PROM (Patient-Reported Outcome Measure) and PREM (Patient-Reported Experience Measure) perspective. A new questionnaire, the Paediatric Eye Questionnaire (PedEyeQ) was developed in the United States in 2019 for children and adolescents aged 0-17 years (3). Since its introduction, it has been used in English and subsequently translated into Spanish. The questionnaire comprises four domains measuring different aspects of vision-related quality of life, with each domain consisting of ten questions. To achieve a comprehensive understanding, the questionnaire incorporates both the child's and the parent's perspectives, and it includes separate age-appropriate versions for different developmental stages.

The aim of this study is to validate the PedEyeQ on a healthy Swedish cohort and to study the prevalence and changes in the amount of refractive errors in the same cohort and compare them to another healthy cohort investigated two decades ago.

Validation of PedEyeQ: We intend to translate the PedEyeQ into Swedish and validate the instrument in a cohort of healthy children and adolescents born in Sweden. The study group will consist of 300 participants aged 0-17 years, divided into the following age-based subgroups corresponding to the PedEyeQ versions: 0-4 years, 5-11 years, and 12-17 years, with 100 participants in each group. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population. Recruitment will primarily take place through child healthcare centers, preschools, and schools in Örebro and surrounding areas.

Participants will be invited to the ophthalmology clinic for a comprehensive examination, including: assessment of distance and near visual acuity, optical coherence tomography (OCT) to document retinal structure, PedEyeQ for assessment of vision-related quality of life, and PedsQL (Pediatric Quality of Life Inventory) for assessment of general quality of life.

For children aged 0-4 years, only parents will complete the quality-of-life assessment. In the older groups, both the child and the parents will complete the questionnaires independently, allowing for comparison between the two perspectives.

The validation process will follow the International Society for Pharmacoeconomics and Outcome Research (ISPOR) recommendations for the translation and cultural adaptation of questionnaires (4). The original American PedEyeQ will be translated using a forward-backward translation procedure. The forward translation from English to Swedish will be carried out by a physician with strong subject knowledge and proficiency in both languages. The translation will be reviewed and proofread by an expert panel consisting of the principal supervisor and co-supervisors. The finalized Swedish version will then be back-translated into English. Emphasis during translation will be placed on conceptual and cultural equivalence, rather than literal translation. The research team will discuss any discrepancies between the original and back-translated versions to establish a final Swedish version of the instrument.

The Swedish questionnaire will then be tested in the described healthy study population. To ensure that participants can understand and adequately respond to the items, all participants will take part in a cognitive interview regarding the questionnaire. Following data collection, psychometric analyses will be conducted to evaluate validity, reliability, reproducibility, responsiveness, and factor structure.

Prevalence of refractive errors - The cohort described above will be recruited as previously outlined. In addition to completing the questionnaires, all participating children will undergo a comprehensive ophthalmological examination according to a standardized protocol, which includes measurements of several factors influencing ocular refraction.

The examination will include: Assessment of distance and near visual acuity, autorefractor measurements both with and without cycloplegia (i.e., after administration of dilating eye drops to temporarily suspend accommodation and obtain accurate refraction values), Optical Coherence Tomography (OCT) to measure retinal thickness and to detect potential pathology such as edema, deposits, or thinning, Axial length measurement, non-invasive corneal mapping of corneal thickness, curvature, and refractive power using Pentacam, measurement of intraocular pressure using a non-contact, non-anesthetic method, and assessment of contrast sensitivity.

All collected data will be stored in a dedicated, pseudonymized research database (FoU database). Descriptive analyses will be performed to determine the prevalence of refractive errors within the study population. The cohort will also be compared to a corresponding reference group examined during the 1990s, in order to assess potential temporal changes in the prevalence of refractive errors among children and adolescents (5).

For statistical analysis, the Mann-Whitney U test will be used to compare continuous variables, while Fisher's exact test and the Chi-square test will be applied for comparisons of dichotomous variables. Regression analyses will be conducted to explore associations between risk factors and myopia, as well as relationships between myopia and quality of life.

Furthermore, the described cohort will serve as a reference population, allowing for the extraction of age- and sex-matched control groups for future pediatric ophthalmological studies.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

300

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Kind

Akzeptiert gesunde Freiwillige

Ja

Probenahmeverfahren

Wahrscheinlichkeitsstichprobe

Studienpopulation

The study group will be selected from randomised preschools, and schools in Örebro and surrounding areas and we aim to collect a cohort as equal as possible compared to health children in general. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population.

Beschreibung

Inclusion Criteria:

  • Healthy children

Exclusion Criteria:

  • Children with ophthalmological diagnosis followed frequently by the ophthalmological clinic

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Healthy children 0-17 years
The study group will consist of 300 participants aged 0-17 years, divided into the following age-based subgroups corresponding to the PedEyeQ versions: 0-4 years, 5-11 years, and 12-17 years, with 100 participants in each group. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population. Recruitment will primarily take place through child health centers, preschools, and schools in Örebro and surrounding areas.

The examination will include: Assessment of distance and near visual acuity, Autorefraction measurements both with and without cycloplegia (i.e., after administration of dilating eye drops to temporarily suspend accommodation and obtain accurate refraction values), Optical Coherence Tomography (OCT) to measure retinal thickness and to detect potential pathology such as edema, deposits, or thinning, Axial length measurement, Non-invasive corneal mapping of corneal thickness, curvature, and refractive power using Pentacam,Measurement of intraocular pressure using a non-contact, non-anesthetic method, and Assessment of contrast sensitivity.

It will also include questionnaires as the PedEyeQ described earlier, the PedQoL.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Prevalence of refractive errors
Zeitfenster: 1 day
1 day

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

27. Oktober 2024

Primärer Abschluss (Geschätzt)

30. Mai 2027

Studienabschluss (Geschätzt)

30. Mai 2029

Studienanmeldedaten

Zuerst eingereicht

11. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

11. Juni 2026

Zuerst gepostet (Tatsächlich)

17. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

11. Juni 2026

Zuletzt verifiziert

1. Oktober 2025

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • Region Örebro County

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Lebensqualität

Klinische Studien zur ophthalmological examination

Abonnieren